These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25411578)

  • 1. Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.
    Du J; Machado-Vieira R; Maeng S; Martinowich K; Manji HK; Zarate CA
    Drug Discov Today Ther Strateg; 2006; 3(4):519-526. PubMed ID: 25411578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
    Maeng S; Zarate CA
    Curr Psychiatry Rep; 2007 Dec; 9(6):467-74. PubMed ID: 18221626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
    Maeng S; Zarate CA; Du J; Schloesser RJ; McCammon J; Chen G; Manji HK
    Biol Psychiatry; 2008 Feb; 63(4):349-52. PubMed ID: 17643398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.
    Wang J; Jing L; Toledo-Salas JC; Xu L
    Neurosci Bull; 2015 Feb; 31(1):75-86. PubMed ID: 25488282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
    Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
    eNeuro; 2017; 4(1):. PubMed ID: 28275719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test.
    Wolak M; Siwek A; Szewczyk B; Poleszak E; Pilc A; Popik P; Nowak G
    Pharmacol Rep; 2013; 65(4):991-7. PubMed ID: 24145093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
    El Iskandrani KS; Oosterhof CA; El Mansari M; Blier P
    J Psychopharmacol; 2015 Jul; 29(7):792-801. PubMed ID: 25759403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine and other potential glutamate antidepressants.
    Dutta A; McKie S; Deakin JFW
    Psychiatry Res; 2015 Jan; 225(1-2):1-13. PubMed ID: 25467702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?
    Freudenberg F; Celikel T; Reif A
    Neurosci Biobehav Rev; 2015 May; 52():193-206. PubMed ID: 25783220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
    Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
    BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine.
    Wei Z; Zhang K; Zhou Q; Huang M; Xu T; Dong J; Zheng Y; Cai X
    CNS Neurol Disord Drug Targets; 2017; 16(7):846-853. PubMed ID: 28462695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on NMDA antagonists in depression.
    Pochwat B; Nowak G; Szewczyk B
    Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid-acting antidepressants.
    Witkin JM; Martin AE; Golani LK; Xu NZ; Smith JL
    Adv Pharmacol; 2019; 86():47-96. PubMed ID: 31378256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.
    Matveychuk D; Thomas RK; Swainson J; Khullar A; MacKay MA; Baker GB; Dursun SM
    Ther Adv Psychopharmacol; 2020; 10():2045125320916657. PubMed ID: 32440333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.